CI 949

Known as: CI-949 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-1993
012319891993

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The toxicity of CI-949, an effective inhibitor of allergic mediator release in pharmacology models, was evaluated in rodents and… (More)
Is this relevant?
1991
1991
The effect of CI-949, a novel inhibitor of allergic mediator release, on immune function was assessed with holistic mouse models… (More)
Is this relevant?
1991
1991
CI-949 is an orally effective inhibitor of allergic mediator release as measured with in vitro and animal models. To assess the… (More)
Is this relevant?
1990
1990
The allergic mediator release inhibitor CI-949 [5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H-indole-2-carboxamide… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1990
1990
CI-949 [5-methyl-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H- indole-2- carboxamide, L-arginine salt] inhibits human… (More)
Is this relevant?
1990
1990
CI-949 (5-methoxy-3-(1-methyl-ethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H -indole-2-carboxamide) effectively inhibited the release of… (More)
Is this relevant?
1990
1990
The novel antiallergy compound, 5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H- indole-2- carboxamide, L-arginine… (More)
Is this relevant?
1989
1989
The immunotoxic properties of two experimental antiallergic drugs, CI-949 and CI-959, were investigated. Wistar rats were gavaged… (More)
Is this relevant?
1989
1989
CI-949 (5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H-indole-2-carboxamide,l-arginine salt), an antiallergy… (More)
  • table I
  • figure 1
Is this relevant?
1989
1989
The synthesis and antiallergic potential of a series of novel indolecarboxamidotetrazoles are described. A number of compounds… (More)
Is this relevant?